David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCHW
3301
PUT
Charles Schwab
SCHW
$189B
| $1.21M | ﹤0.01% |
16,600
+5,900
| +55% | +$421K |
|
|
RETA
3302
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.21M | ﹤0.01% |
+12,000
| New | +$1.41M |
|
3303
PUT
NeoGenomics
NEO
$2.23B
| $1.21M | ﹤0.01% |
25,000
| – | – |
|
|
GLAQ
3304
DELISTED
Globis Acquisition Corp. common stock
GLAQ
| $1.21M | ﹤0.01% |
120,034
+11,271
| +10% | +$113K |
|
3305
PUT
Kimberly-Clark
KMB
$36.7B
| $1.21M | ﹤0.01% |
9,100
-4,400
| -33% | -$598K |
|
|
FAAS
3306
DELISTED
DigiAsia
FAAS
| $1.2M | ﹤0.01% |
+120,416
| New | +$1.19M |
|
3307
CALL
Kaiser Aluminum
KALU
$2.54B
| $1.2M | ﹤0.01% |
11,000
| – | – |
|
3308
Pricesmart
PSMT
$5.41B
| $1.2M | ﹤0.01% |
15,455
+12,546
| +431% | +$1.06M |
|
|
CDMO
3309
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.2M | ﹤0.01% |
55,521
+28,200
| +103% | +$681K |
|
|
CTRA
3310
PUT
DELISTED
Coterra Energy
CTRA
| $1.2M | ﹤0.01% |
+54,937
| New | +$942K |
|
3311
Associated Banc-Corp
ASB
$5.83B
| $1.19M | ﹤0.01% |
55,747
+30,744
| +123% | +$625K |
|
3312
CALL
Enbridge
ENB
$110B
| $1.19M | ﹤0.01% |
30,000
| – | – |
|
|
TWCBU
3313
DELISTED
Bilander Acquisition Corp. Unit
TWCBU
| $1.19M | ﹤0.01% |
+119,603
| New | +$1.18M |
|
3314
Carlisle Companies
CSL
$14.5B
| $1.19M | ﹤0.01% |
5,999
-6,376
| -52% | -$1.29M |
|
3315
CALL
Northern Oil and Gas
NOG
$2.77B
| $1.19M | ﹤0.01% |
55,700
| – | – |
|
|
RAD
3316
DELISTED
Rite Aid Corporation
RAD
| $1.19M | ﹤0.01% |
83,946
+61,749
| +278% | +$972K |
|
3317
Honda
HMC
$40.8B
| $1.19M | ﹤0.01% |
38,842
+9,150
| +31% | +$288K |
|
3318
PUT
Yeti Holdings
YETI
$3.05B
| $1.19M | ﹤0.01% |
+13,900
| New | +$1.35M |
|
|
ELIQ
3319
DELISTED
Electriq Power Holdings, Inc.
ELIQ
| $1.19M | ﹤0.01% |
120,459
| – | – |
|
3320
Digital Realty Trust
DLR
$71.8B
| $1.19M | ﹤0.01% |
8,207
+6,612
| +415% | +$1.04M |
|
3321
HUTCHMED
HCM
$2.15B
| $1.19M | ﹤0.01% |
32,364
+25,202
| +352% | +$991K |
|
|
VMEO
3322
DELISTED
Vimeo
VMEO
| $1.18M | ﹤0.01% |
40,227
+13,842
| +52% | +$546K |
|
|
SEI
3323
Solaris Energy Infrastructure
SEI
$3.41B
| $1.18M | ﹤0.01% |
141,608
+101,951
| +257% | +$827K |
|
3324
CALL
Realty Income
O
$58.9B
| $1.18M | ﹤0.01% |
18,782
+8,462
| +82% | +$571K |
|
3325
Barings BDC
BBDC
$979M
| $1.18M | ﹤0.01% |
106,792
-26,024
| -20% | -$281K |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $13.7B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.